findmyKOL
Clinical trialNCT05194982RecruitingPhase 1Interventional

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

SponsorSichuan Baili Pharmaceutical Co., Ltd.Enrollment570Locally Advanced or Metastatic Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, China

    Recruiting
  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, China

    Li Zhang, PHD
    Recruiting
  • the Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

    Recruiting
  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China

    Recruiting
  • Union Hospital Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Recruiting
  • Hunan Cancer Hospital

    Changsha, Hunan, China

    Recruiting
  • Shanghai Oriental Hospital

    Shanghai, Shanghai Municipality, China

    Recruiting
  • Shanxi Cancer Hospital

    Taiyuan, Shanxi, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Nov 2021
Primary completion
31 Dec 2026
Completion
31 Dec 2027
Last update posted
26 Sept 2025
Registered enrollment
570
Registry id
NCT05194982

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.